API Gallery
The Lactobacillus rhamnosus market is projected to grow at a CAGR of 7.1% from 2025 to 2035, driven by rising demand for probiotics across pharmaceutical, nutraceutical, and functional food sectors.
The Lactobacillus sporogenes market is projected to grow at a CAGR of 6.8% from 2025 to 2035, driven by its reclassified name Bacillus coagulans, is witnessing robust growth owing to rising demand in pharmaceutical, nutraceutical, and animal health industries.
The Lamivudine API market is projected to grow at a CAGR of 3.9% from 2025 to 2035, driven by the rising prevalence of HIV/AIDS and chronic hepatitis B infections.
The LCZ 696 (Entresto) API market is projected to grow at a CAGR of 7.2% from 2025 to 2035, driven by the rising prevalence of heart failure globally and increased adoption of advanced cardiovascular therapies.
The L-Histidine API market is projected to grow at a CAGR of 4.3% from 2025 to 2035, fueled by increasing demand in the pharmaceutical and nutraceutical sectors.
The L-Leucine N-carboxyanhydride (L-Leu NCA) API market is projected to grow at a CAGR of 6.1% from 2025 to 2035, driven by increasing demand for advanced peptide synthesis technologies and biodegradable polymers in pharmaceuticals and biotechnology.
The L-Methionine API market is projected to grow at a CAGR of 5.2% from 2025 to 2035, driven by its essential role in human and animal health.
The losartan potassium API market is projected to grow at a CAGR of 7.2% from 2025 to 2035, driven by increasing prevalence of hypertension and cardiovascular diseases.
The L-Valine N-carboxyanhydride (L-Val NCA) market is projected to grow at a CAGR of 5.4% from 2025 to 2035, driven by increasing demand for peptide-based therapeutics and biodegradable polymers.
The Acetonitrile market is witnessing a CAGR of 4.5% during the forecast period of 2025-2035. And it is expanding rapidly, owing to its various applications in medicines, chemical synthesis, agrochemicals, and laboratory research.
The Cisatracurium Besylate market is anticipated to grow at a CAGR of 4.1%, forecasted for 2025 to 2035, owing to expanding demand for neuromuscular blocking agents for use in surgeries, critical care, and emergency medicine.
Search from 10,000 + API reports
How can we help you?
Reach out to discuss how our team can help your business achieve real results.